Sulphasalazine, an inexpensive drug used for arthritis and inflammatory bowel disease, can reverse the scarring associated with cirrhosis of the liver, according to scientists at the University of Newcastle in the UK.
Previously thought to be irreversible, new research on animals has found that the scarring damage can be reversed with the drug. If research with humans conforms these findings, it may mean that use of the drug could eliminate the need for liver transplants.
The scientists will start clinical trials with previously heavy drinkers who no longer drink and whose livers are heavily scarred.
Either abstaining from alcohol or consuming it in moderation can not only prevent cirrhosis of the liver caused by alcohol abuse but many other health risks.
Filed Under: Health